Kennon-Green & Company’s AbbVie ABBV Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $277K | Buy |
1,460
+15
| +1% | +$2.85K | 0.22% | 38 |
|
|
2025
Q1 | $303K | Sell |
1,445
-25
| -2% | -$5.24K | 0.25% | 39 |
|
|
2024
Q4 | $261K | Sell |
1,470
-30
| -2% | -$5.33K | 0.23% | 41 |
|
|
2024
Q3 | $296K | Sell |
1,500
-4
| -0.3% | -$790 | 0.25% | 40 |
|
|
2024
Q2 | $258K | Sell |
1,504
-77
| -5% | -$13.2K | 0.24% | 40 |
|
|
2024
Q1 | $288K | Sell |
1,581
-25
| -2% | -$4.55K | 0.27% | 40 |
|
|
2023
Q4 | $249K | Sell |
1,606
-105
| -6% | -$16.3K | 0.25% | 40 |
|
|
2023
Q3 | $255K | Sell |
1,711
-46
| -3% | -$6.86K | 0.25% | 43 |
|
|
2023
Q2 | $237K | Sell |
1,757
-25
| -1% | -$3.37K | 0.22% | 43 |
|
|
2023
Q1 | $284K | Sell |
1,782
-75
| -4% | -$12K | 0.27% | 40 |
|
|
2022
Q4 | $300K | Buy |
+1,857
| New | +$300K | 0.3% | 37 |
|